IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Candriam S.C.A.

Q4 2015 Holdings

Filed 2016-01-25 | 553 holdings | $232.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$23.5M224,27910.1%
Abbvie Inc(ABBV)COM00287Y109$33.0M557,68214.2%
Biogen Inc(BIIB)COM09062X103$74.4M243,01932.1%
PreviousPage 12 of 12